Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TwinMet: Metformin for Preterm Birth Prevention in Twin Pregnancy
NCT05412056Phase 3Unknown
- Sponsor
- The University of Hong Kong
- Start
- Jun 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in preterm birth, sponsored by The University of Hong Kong. Primary endpoint: Preterm birth before 34+0 gestational weeks at 34 weeks. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT05412056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05412056.